Biophore India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
- Paid Up Capital ₹ 1.06 Cr
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 94.98 Cr
- Satisfied Charges ₹ 26.75 Cr
- Revenue Growth -6.69%
- Profit Growth 43.88%
- Ebitda 28.71%
- Net Worth 35.97%
- Total Assets 24.31%
About Biophore India Pharmaceuticals
Biophore India Pharmaceuticals Private Limited (BIPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 March 2007 and has a history of 18 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.06 Cr.
The company currently has active open charges totaling ₹94.98 Cr. The company has closed loans amounting to ₹26.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhusudana Kothapalli, Jagadeesh Rangisetty, Manikreddy Pullagurla, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2007PTC053381
- Company No.
053381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Biophore India Pharmaceuticals Private Limited offer?
Biophore India Pharmaceuticals Private Limited offers a wide range of products and services, including Turnkey Consultants & Solutions, Project Feasibility Studies, Nutraceuticals & Dietary Supplements, Dietary Supplements, Environment Protection & Auditing, Environment Protection Services, Building & Real Estate Developers, Construction Service.
Biophore India Pharmaceuticals Private Limited
Explore comprehensive data for Biophore India Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Biophore India Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeesh Rangisetty  | Managing Director | 29-Mar-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhusudana Kothapalli | Director | 15-Nov-2017 | Current |
| Manikreddy Pullagurla | Director | 22-Aug-2009 | Current |
Harcharan Singh  | Director | 10-Jul-2015 | Current |
Financial Performance of Biophore India Pharmaceuticals.
Biophore India Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.69% decrease. The company also saw a substantial improvement in profitability, with a 43.88% increase in profit. The company's net worth Soared by an impressive increase of 35.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biophore India Pharmaceuticals?
In 2023, Biophore India Pharmaceuticals had a promoter holding of 31.69% and a public holding of 68.31%. The company had 3 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Glopec International (India) Private LimitedHarcharan Singh is a mutual person
Azico Biophore India Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Leiutis Pharmaceuticals LlpMadhusudana Kothapalli, Jagadeesh Rangisetty and 2 more are mutual person
- Zenara Pharma Private Limited
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
- Alithia Pharmaceuticals Private Limited
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Sionc Pharmaceuticals Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Charges (Loans)
Open Charges
₹94.98 Cr
Satisfied Charges
₹26.75 Cr
Charges Breakdown by Lending Institutions
- Others : 91.75 Cr
- Hdfc Bank Limited : 2.55 Cr
- Axis Bank Limited : 0.68 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jul 2022 | Others | ₹27.00 Cr | Open |
| 31 Mar 2021 | Hdfc Bank Limited | ₹1.28 Cr | Open |
| 15 Feb 2021 | Hdfc Bank Limited | ₹1.28 Cr | Open |
| 23 Sep 2020 | Others | ₹5.74 Cr | Open |
| 26 Sep 2019 | Axis Bank Limited | ₹2.09 M | Open |
How Many Employees Work at Biophore India Pharmaceuticals?
Biophore India Pharmaceuticals has a workforce of 593 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biophore India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biophore India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Biophore India Pharmaceuticals
Recent activity within the organization
- Charges
A charge with Others of Rs. 59.01 Cr registered on 25 Mar 2015 with Charge ID 10585647 was modified on 30 Oct 2024.
- Annual General Meeting
Biophore India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Biophore India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Charges
A charge with Others of Rs. 27.00 Cr registered on 12 Jul 2022 with Charge ID 100600081 was modified on 03 Oct 2023.
- Charges
A charge with Others amounted to Rs. 27.00 Cr with Charge ID 100600081 was registered on 12 Jul 2022.
- Charges
A charge registered on 07 Jan 2020 via Charge ID 100327203 with Axis Bank Limited was fully satisfied on 30 Sep 2021.
Recent News, Updates & Announcement
- Akums enters into a pact with Leiutis, Biophore for bringing therapeutics to India.
This association is set to bring succour in therapy areas of CNS disorders, pain management, and hormonal disorders, where there is a gap in meeting the needs of patients in an effective, safe, and convenient manner. .
- Oakrum Pharma and Biophore Announce Product Development and Commercialization Partnership.
/PRNewswire/ -- Oakrum Pharma, LLC (Oakrum) announced today that it has entered into an agreement with Biophore India Pharmaceuticals Pvt. Ltd. (Biophore) to....
- Amerigen and Biophore Collaborate on Penicillamine Generics.
Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant's Cuprimine and other penicillamine based generic products to the U.S. market using active pharmaceutical ingredient supplied by Biophore from India. .
Frequently asked questions
What is the Incorporation or founding date of Biophore India Pharmaceuticals Private Limited?
Biophore India Pharmaceuticals Private Limited was incorporated on 29 Mar 2007.
What is authorized share capital and paid-up capital of Biophore India Pharmaceuticals Private Limited?
The authorized share capital of Biophore India Pharmaceuticals Private Limited is ₹ 1.10 Cr and paid-up capital is ₹ 1.06 Cr.
Who are the current board members & directors of Biophore India Pharmaceuticals Private Limited?
Currently 4 directors are associated with Biophore India Pharmaceuticals Private Limited.
- Madhusudana Rao Kothapalli
- Jagadeesh Babu Rangisetty
- Manikreddy Pullagurla
- Harcharan Singh
What is the registered address of Biophore India Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Biophore India Pharmaceuticals Private Limited is Plot No: 92 1-98/2/92 Kavuri Hills Phase-Ii, Jubilee India, Hyderabad, Telangana, 500033.
What is the corporate identification number (CIN) and company number of Biophore India Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Biophore India Pharmaceuticals Private Limited is U24232TG2007PTC053381 and the company number is 053381 as per Ministry of Corporate Affairs (MCA).
What is the official website of Biophore India Pharmaceuticals Private Limited?
The Official website of Biophore India Pharmaceuticals Private Limited is https://www.biophore.com
What has been the recent revenue trend for Biophore India Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Biophore India Pharmaceuticals Private Limited has fallen by -6.69%.
How many employees does Biophore India Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 593 employees are currently employed by Biophore India Pharmaceuticals Private Limited.
What change has been observed in the net worth of Biophore India Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Biophore India Pharmaceuticals Private Limited has experienced an upsurge of 35.97%.
What are the total open charges for Biophore India Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Biophore India Pharmaceuticals Private Limited amount to ₹ 94.98 Cr.
When was the last Balance Sheet of Biophore India Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Biophore India Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Ravibabu KothapalliDirectorRN
Ramprasad NimmagaddaDirector
Similar Companies Based on Pharma Contract R&D
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Msn Laboratories Private Limited Rangareddy, Telangana, India
Lupin Limited Mumbai, Maharashtra, India
Ipca Laboratories Limited Mumbai, Maharashtra, India
Divi's Laboratories Limited Rangareddy, Telangana, India
Hetero Labs Limited Rangareddy, Telangana, India
Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India